Promomed (PRMD) EV/EBITDA MSFO (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 0.88 | 1.52 | 2.48 | 11.2 | 10.2 | ||
| Changes by years, y/y, % | +73% | +64% | +350% | +133.5% | ||||
Promomed. EV/EBITDA
Promomed. EV/EBITDA, changes, %
Promomed (PRMD) EV/EBITDA MSFO (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EV/EBITDA | ? | 2.07 | 9.17 | 11.2 | 11.1 | 10.5 | 10.2 | |
| Changes by years, y/y, % | +440% | +395% | +409% | |||||
| Changes by quarters, q/q, % | -8% | +344% | +22% | -1% | -5% | |||